An exceptional group of internationally recognized scientists and clinicians will convene in Boston for the 2026 Activated Egg Symposium, a one-day meeting focused on one of the most fundamental questions in reproductive and developmental biology: how human eggs activate and begin early embryonic development. The event, titled "Unique Human Egg Activation Pathways," is part of a series hosted by the Bedford Research Foundation since 2002 and is designed to foster scientific exchange, spark new collaborations, and bring experts from academia, fertility clinics, and biotechnology together to explore the molecular and cellular mechanisms that shape human egg activation, fertilization, and developmental competence.
The symposium will offer a rare opportunity for researchers, clinicians, trainees, and innovators to engage directly with leaders whose work has helped define modern reproductive biology, stem cell science, and regenerative medicine. The program will feature presentations spanning ovarian biology, fertilization, calcium signaling, genome stability, cellular reprogramming, stem cell-based models of early development, and the biological foundations of successful embryo development. By uniting leading voices across disciplines and sectors, the symposium aims to foster meaningful dialogue, encourage new partnerships, and accelerate translational progress in fertility and developmental science.
"We still have fundamental questions about how human eggs develop, and answering them could open new possibilities in reproductive and regenerative medicine," said Ann A. Kiessling, Director of the Bedford Research Foundation. The featured speakers include Evelyn Telfer, Professor and Chair of Reproductive Biology at the University of Edinburgh; Ali H. Brivanlou of The Rockefeller University; Rafael Fissore of the University of Massachusetts Amherst; Ehsan Habibi of the Ottawa Hospital Research Institute and University of Ottawa; Jonathan van Blerkom of the University of Colorado, Boulder; Dietrich M. Egli of Columbia University Irving Medical Center; and Elizebeth Carr, America's first IVF baby, speaker and advocate. Collectively, these speakers represent pioneering work in ovarian biology, fertilization, egg activation, developmental competence, nuclear transfer, pluripotency, synthetic embryology, and genome stability in early development.
The symposium's translational relevance is significant. Discoveries discussed could have implications for fertility treatment, assisted reproduction, stem cell science, and developmental medicine. For the fertility industry, a deeper understanding of egg activation may lead to improved success rates in assisted reproduction and new approaches to treating infertility. In regenerative medicine, insights into cellular reprogramming and stem cell-based models of early development could inform new therapies for a range of diseases. The focused one-day format is built to maximize scientific exchange, audience engagement, and collaboration, providing a high-impact opportunity for attendees to connect with leaders in the field.
As reproductive science continues to advance, the 2026 Activated Egg Symposium stands as a critical forum for addressing unanswered questions that could shape the future of human health. The gathering underscores the importance of cross-sector collaboration in translating basic research into clinical and commercial applications, with potential benefits for patients and the broader biotechnology and healthcare industries.
